Newron Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 116,972 | 0.628% |
Private Companies | 785,448 | 4.22% |
Institutions | 1,514,916 | 8.13% |
General Public | 16,214,498 | 87% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
785,448 | US$6.4m | 0% | no data | |||
750,000 | US$6.1m | 0% | 3.51% | |||
249,488 | US$2.0m | 3.71% | no data | |||
175,514 | US$1.4m | 14.1% | no data | |||
114,600 | US$931.6k | 0% | no data | |||
99,850 | US$811.7k | 0% | 0.01% | |||
41,872 | US$340.4k | 0% | no data | |||
40,249 | US$327.2k | 0% | no data | |||
36,106 | US$293.5k | 9.84% | no data | |||
32,760 | US$266.3k | 0% | no data | |||
25,000 | US$203.2k | 0% | 0.43% | |||
24,039 | US$195.4k | 35.5% | 0.01% | |||
20,351 | US$165.4k | 0% | no data | |||
12,000 | US$97.6k | 140% | no data | |||
3,619 | US$29.4k | 0% | no data | |||
2,500 | US$20.3k | 0% | no data | |||
2,463 | US$20.0k | 0% | no data | |||
1,477 | US$12.0k | 0% | no data |